Woisetschläger, Mischa https://orcid.org/0000-0003-0066-4985
Baldimtsi, Evangelia https://orcid.org/0000-0002-4433-1376
Lindblom, Maria
Davidson, Thomas
Bjerner, Tomas https://orcid.org/0000-0001-9548-4842
Spångeus, Anna https://orcid.org/0000-0002-7130-9158
Funding for this research was provided by:
VINNOVA (AIDA/Medtech4Health (Vinnova))
VINNOVA (Medtech4Health (Vinnova))
ALF Grants, Region Östergötland
Linköping medical society
Linköping University
Article History
Received: 2 November 2025
Accepted: 12 February 2026
First Online: 10 March 2026
Declarations
:
: Ethical approval was obtained from the Swedish Ethical Review Authority (Approval No. 2024–05075-01). The study complied with institutional and national research ethics standards and adhered to the principles of the Declaration of Helsinki and its amendments. The requirement for informed consent was waived by the Swedish Ethical Review Authority.
: Author AS has received honoraria for lectures from UCB, Amgen, Sandoz, and AstraZeneca and has served on an advisory board for UCB. Authors MW, EB, ML, TD and TB declare no conflicts of interest related to this work.
: Not applicable.